Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Daniel Pollyea

Concepts (473)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Daniel Pollyea's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Daniel Pollyea has written about over time.
Hematopoietic Stem Cell Transplantation, 17 publications between 2006 and 2024, average publication date August 2017. Hematologic Neoplasms, 10 publications between 2006 and 2023, average publication date December 2017. Prognosis, 29 publications between 2006 and 2025, average publication date February 2018. Antineoplastic Agents, 25 publications between 2006 and 2025, average publication date March 2018. Neoplasm Recurrence, Local, 6 publications between 2007 and 2025, average publication date April 2018. Remission Induction, 16 publications between 2010 and 2026, average publication date July 2018. Myelodysplastic Syndromes, 29 publications between 2007 and 2025, average publication date October 2018. Isocitrate Dehydrogenase, 13 publications between 2012 and 2022, average publication date October 2018. Mutation, 36 publications between 2010 and 2025, average publication date November 2018. Aminopyridines, 7 publications between 2017 and 2021, average publication date February 2019. Triazines, 7 publications between 2017 and 2021, average publication date February 2019. Graft vs Host Disease, 9 publications between 2007 and 2024, average publication date May 2019. Neoplastic Stem Cells, 14 publications between 2014 and 2025, average publication date November 2019. Leukemia, Myeloid, Acute, 115 publications between 2007 and 2026, average publication date February 2020. RNA Splicing Factors, 3 publications between 2019 and 2020, average publication date April 2020. Antineoplastic Combined Chemotherapy Protocols, 50 publications between 2010 and 2026, average publication date May 2020. Azacitidine, 24 publications between 2011 and 2026, average publication date November 2020. Neoplasm, Residual, 7 publications between 2012 and 2024, average publication date December 2020. Sulfonamides, 34 publications between 2016 and 2026, average publication date July 2021. Bridged Bicyclo Compounds, Heterocyclic, 39 publications between 2016 and 2026, average publication date October 2021.

To see the data from this visualization as text, click here.
Pollyea's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)